Celularity (CELU) Announces CFO Transition

Go back to Celularity (CELU) Announces CFO Transition

Celularity Announces Chief Financial Officer Transition

June 10, 2025 4:15 PM UTC

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (Celularity or the Company), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (CFO), David Beers, effective immediately. Mr. Beers termination was not related to the Companys financial or operating results or to any disagreements or concerns regarding the Companys financial or reporting practices. Mr. Beers was terminated without cause under the terms of his employment agreement dated April 1, 2022, as... More